Jason A. Okazaki's Insider Trades & SAST Disclosures
Jason A. Okazaki's most recent trade in Assembly Biosciences Inc was a trade of 197 Common Stock done at an average price of $14.8 . Disclosure was reported to the exchange on Oct. 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jason A. Okazaki.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.81 per share. | 03 Oct 2024 | 197 | 14,904 (0%) | 0% | 14.8 | 2,918 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 02 Aug 2024 | 981 | 15,101 (0%) | 0% | 14.2 | 13,962 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.93 per share. | 23 May 2024 | 549 | 16,082 (0%) | 0% | 14.9 | 8,199 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 4,166 | 17,992 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 12.71 per share. | 29 Apr 2024 | 1,569 | 16,423 (0%) | 0% | 12.7 | 19,937 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 29 Mar 2024 | 354 | 13,826 (0%) | 0% | 13.1 | 4,627 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 12.87 per share. | 27 Mar 2024 | 392 | 14,180 (0%) | 0% | 12.9 | 5,045 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 02 Aug 2023 | 11,827 | 164,786 (0%) | 0% | 1.1 | 12,867 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 50,000 | 176,613 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 35,000 | 133,174 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 22 May 2023 | 6,561 | 126,613 (0%) | 0% | 1.0 | 6,825 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 470,000 | 470,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 29 Mar 2023 | 4,247 | 98,174 (0%) | 0% | 0.8 | 3,496 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 27 Mar 2023 | 4,693 | 102,421 (0%) | 0% | 1.0 | 4,785 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 12,500 | 107,114 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 31,250 | 95,883 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 31,250 | 31,250 | - | - | Performance-based Restricted Stock Units | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 29 Mar 2022 | 1,269 | 94,614 (0%) | 0% | 2.2 | 2,750 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 28 Mar 2022 | 4,617 | 64,633 (0%) | 0% | 2.2 | 10,363 | Common Stock |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Legal & Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 82,500 | 82,500 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Legal & Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 13,750 | 67,250 (0%) | 0% | 0 | Common Stock | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Legal & Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2020 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Chief Legal & Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2020 | 50,000 | 52,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges